Home  /  Resource Library  /  Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: a phase II risk-adapted design

Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: a phase II risk-adapted design

Results of a study investigating ofatumumab combined with bendamustine for first line treatment of elderly patients with mantle cell lymphoma.